1 the applicant is the owner of the therapeutic drug coversyl (active ingredient - perindopril) which has three registered indications for treatment: hypertension, chronic heart fatigue and coronary artery disease.
the respondent is the producer of perindopril erbumine products are the generic version of coversyl.
associate: dated: 30 november 2006 counsel for the applicant: d shavin qc and i horak solicitors for the applicant: clayton utz counsel for the respondent: s mcvicar solicitors for the respondent: freehills date of hearing: 30 november 2006 date of judgment: 30 november 2006 austlii: copyright policy | disclaimers | privacy policy | feedback url: http://www.austlii.edu.au/au/cases/cth/fca/2006/1763.html